Ch. Jin et al., TRANSCRIPTIONAL ACTIVATION AND DIMERIZATION FUNCTIONS IN THE HUMAN VITAMIN-D-RECEPTOR, Molecular endocrinology, 10(8), 1996, pp. 945-957
The C-terminal domain of the human vitamin D receptor (hVDR) is essent
ial for dimerization with retinoid X receptors and for transcriptional
activation. To define the dimerization domain of the hVDR, a series o
f internal deletion mutants of the receptor were prepared beginning wi
thin the E domain and extending through the F domain to the C terminus
. These mutant receptors were tested for dimerization and transcriptio
nal activities by means of gel shift assay and beta-galactosidase assa
y, respectively, in a yeast system. The dimerization domain of the hVD
R was localized to two separate but adjacent regions of the receptor m
olecule. In these experiments, the activation domain colocalized with
dimerization, To more precisely delineate a relationship between these
domains, region-specific random mutagenesis was carried out to detect
mutants using error-prone PCR and a functional screen strategy employ
ed using transformed yeast. Two classes of inactive receptors were ide
ntified: one in which both transcriptional activation and dimerization
were compromised and a second in which only transcriptional activatio
n was abolished, Most of the mutations responsible for these phenotype
s were single. The studies suggest a separation between dimerization a
nd transactivation domains. We reconstituted each of these hVDR mutant
s in a mammalian expression vector and evaluated them individually in
COS-1 cells. All VDR mutants were transcriptionally active in this cel
lular background in response to 1,25-dihydroxyvitamin D-3, although th
e potency of the hormone was reduced. The latter observation coincided
with the observation that each mutant was compromised to some extent
in binding affinity. These data clearly demonstrate the existence of a
n activation domain in hVDR that is separable from the domain involved
in dimerization, Factors that couple hVDR to the general transcriptio
n apparatus in yeast through the activation domain in the hVDR, howeve
r, appear to be unrelated or dissimilar to those used in COS-1 cells.